Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1Genital Neoplasms, Female 1

Interventions

Paclitaxel 4Carboplatin 4Pemetrexed 2Palliative Care 2Gemcitabine 2temsirolimus 1rucaparib 1pembrolizumab 1niraparib 1nintedanib 1nilotinib 1liposomal doxorubicin 1fosaprepitant 1atezolizumab 1argatroban 1Topotecan 1Thrombopoietin 1Palonosetron 1Ocoxin 1Laparoscopy 1Heparin, Low-Molecular-Weight 1Filgrastim 1Electrocardiography 1Educational Status 1Dexamethasone 1Darbepoetin alfa 1Cognitive Behavioral Therapy 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Genital Neoplasms, Female × argatroban × Clear all
NCT02935530 2019-05-14

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Huazhong University of Science and Technology

Phase 3 Completed
315 enrolled
Classical hematology

Genital Neoplasms, Female, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡